| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/SEXTRANS-2012-050709 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC3512432 |
| https://europepmc.org/articles/PMC3512432?pdf=render | ||
| https://sti.bmj.com/content/sextrans/88/Suppl_2/i44.full.pdf | ||
| https://syndication.highwire.org/content/doi/10.1136/sextrans-2012-050709 | ||
| P932 | PMC publication ID | 3512432 |
| P698 | PubMed publication ID | 23172345 |
| P5875 | ResearchGate publication ID | 233766002 |
| P50 | author | Renaud Becquet | Q55454965 |
| Louise Kuhn | Q61451544 | ||
| Nigel Rollins | Q79179985 | ||
| Lynne Mofenson | Q43882680 | ||
| P2093 | author name string | Mary Mahy | |
| Tracy Creek | |||
| P2860 | cites work | 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G | Q43935041 |
| A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. | Q44323692 | ||
| Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand | Q44973302 | ||
| Antiretroviral drugs in the cupboard are not enough: the impact of health systems' performance on mother-to-child transmission of HIV. | Q45243030 | ||
| Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 2002-2006. | Q45375764 | ||
| Human immunodeficiency virus type 1 (HIV-1) seroconversion during pregnancy does not increase the risk of perinatal transmission | Q45854251 | ||
| Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening | Q46247159 | ||
| Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire | Q46429703 | ||
| Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission | Q46558677 | ||
| Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000???2006 | Q57076315 | ||
| Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial | Q64131584 | ||
| Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group | Q64131586 | ||
| Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation. The French Pediatric HIV Infection Study Group | Q72452485 | ||
| HIV seroconversion during pregnancy and risk for mother-to-infant transmission | Q73794466 | ||
| A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feeding | Q84281670 | ||
| Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women | Q24236763 | ||
| Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group | Q28239283 | ||
| Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study | Q28744042 | ||
| Confronting Challenges in Monitoring and Evaluation: Innovation in the Context of the Global Plan Towards the Elimination of New HIV Infections Among Children by 2015 and Keeping Their Mothers Alive | Q30234858 | ||
| Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis | Q30936851 | ||
| Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach | Q33294899 | ||
| Spectrum: a model platform for linking maternal and child survival interventions with AIDS, family planning and demographic projections | Q33754434 | ||
| Triple-Antiretroviral Prophylaxis to Prevent Mother-To-Child HIV Transmission through Breastfeeding—The Kisumu Breastfeeding Study, Kenya: A Clinical Trial | Q33863552 | ||
| Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial | Q33873955 | ||
| Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa | Q33893057 | ||
| Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival | Q33986352 | ||
| Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to- child HIV transmission | Q34157776 | ||
| Antiretroviral regimens in pregnancy and breast-feeding in Botswana | Q34395082 | ||
| Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study | Q34614259 | ||
| Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial | Q34634644 | ||
| Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda | Q34729160 | ||
| The Spectrum projection package: improvements in estimating incidence by age and sex, mother-to-child transmission, HIV progression in children and double orphans | Q35215002 | ||
| Risk of human immunodeficiency virus type 1 transmission through breastfeeding | Q35263935 | ||
| Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda | Q35834097 | ||
| Maternal or infant antiretroviral drugs to reduce HIV-1 transmission | Q36231035 | ||
| Lessons learnt from promising practices in community engagement for the elimination of new HIV infections in children by 2015 and keeping their mothers alive: summary of a desk review | Q36404500 | ||
| Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission | Q36776545 | ||
| Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials | Q38875948 | ||
| Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? | Q38880309 | ||
| Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. | Q38882753 | ||
| Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial | Q38884501 | ||
| Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial | Q38967453 | ||
| Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana | Q40799743 | ||
| Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant | Q42618550 | ||
| Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts | Q43027197 | ||
| Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1). | Q43855412 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vertically transmitted infection | Q4113827 |
| HIV | Q15787 | ||
| HIV transmission | Q49029021 | ||
| P304 | page(s) | i44-51 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | Sexually Transmitted Infections | Q7458852 |
| P1476 | title | Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models | |
| P478 | volume | 88 Suppl 2 |
| Q33865236 | Beyond prevention of mother-to-child transmission: keeping HIV-exposed and HIV-positive children healthy and alive |
| Q38804740 | Changing Dynamics of HIV Transmission in Côte d'Ivoire: Modeling Who Acquired and Transmitted Infections and Estimating the Impact of Past HIV Interventions (1976-2015). |
| Q26749153 | Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan Africa |
| Q38819314 | Co-trimoxazole prophylaxis, asymptomatic malaria parasitemia, and infectious morbidity in HIV-exposed uninfected infants in Malawi: The BAN study |
| Q42380432 | Developments in the field of HIV estimates: methods, parameters and trends |
| Q38181250 | Early infant diagnosis of HIV infection in low-income and middle-income countries: does one size fit all? |
| Q34585124 | Embracing different approaches to estimating HIV incidence, prevalence and mortality |
| Q34585140 | Estimating future trends in paediatric HIV. |
| Q35891055 | Estimating mother-to-child HIV transmission rates in Cameroon in 2011: a computer simulation approach |
| Q34549966 | HIV in children in a general population sample in East Zimbabwe: prevalence, causes and effects |
| Q30062047 | HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. |
| Q38744152 | Improving estimates of children living with HIV from the Spectrum AIDS Impact Model |
| Q33902803 | Individualizing the WHO HIV and infant feeding guidelines: optimal breastfeeding duration to maximize infant HIV-free survival |
| Q38608297 | Infant and Young Child Feeding Decision Making and Practices: Malawian Mothers' and Fathers' Roles in the Context of HIV. |
| Q35079468 | Initial programmatic implementation of WHO option B in Botswana associated with increased projected MTCT |
| Q89919266 | Level and determinants of postpartum adherence to antiretroviral therapy in the Eastern Cape, South Africa |
| Q35017986 | Methodological and policy limitations of quantifying the saving of lives: a case study of the Global Fund's approach |
| Q34991645 | Missing HIV prevention opportunities in South African children--a 7-year review |
| Q33688086 | Modeling the Impact of Retention Interventions on Mother-to-Child Transmission of HIV: Results From INSPIRE Studies in Malawi, Nigeria, and Zimbabwe |
| Q55546839 | Morbidity and mortality in HIV-exposed uninfected children |
| Q90491957 | Mother-to-Child HIV Transmission with in utero Dolutegravir vs. Efavirenz in Botswana |
| Q40470658 | New drug regimens for HIV in pregnancy and a national strategic plan to manage HIV: A South African perspective. |
| Q35984276 | Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection? |
| Q54233568 | Optimal breastfeeding durations for HIV-exposed infants: the impact of maternal ART use, infant mortality and replacement feeding risk |
| Q38789791 | Option B+ for the prevention of mother-to-child transmission of HIV infection in developing countries: a review of published cost-effectiveness analyses. |
| Q28543954 | Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis |
| Q39599829 | Preventing mother-to-child transmission of the human immunodeficiency virus in Southern Africa |
| Q38770529 | Producing HIV estimates: from global advocacy to country planning and impact measurement |
| Q55154875 | Thai national guidelines for the prevention of mother-to-child transmission of human immunodeficiency virus 2017. |
| Q38828635 | Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feeding |
| Q91721510 | Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels |
| Q34585085 | Updates to the spectrum model to estimate key HIV indicators for adults and children |
| Q30384678 | What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach. |
Search more.